Judge Properly Construed pH Claim Term In ANDA Dispute, Federal Circuit Rules
WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel on May 13 affirmed a West Virginia federal judge’s finding that a generic drug maker did not infringe patents describing...To view the full article, register now.
Already a subscriber? Click here to view full article